Immunosuppressants

Results: 1821



#Item
581Chemistry / Bristol-Myers Squibb / Ipilimumab / Monoclonal antibodies / Methadone / Infliximab / Adverse effect / Management of ulcerative colitis / Gp100:209-217 / Medicine / Immunosuppressants / Pharmacology

DATA SHEET YERVOY ® (ipilimumab) 5mg per 1mL concentrate solution for infusion NAME OF THE MEDICINE

Add to Reading List

Source URL: www.medsafe.govt.nz

Language: English - Date: 2015-01-22 22:51:04
582Immunosuppressants / Macrolides / Tacrolimus / Astellas Pharma / Immunology / Graft-versus-host disease / Liver transplantation / Kidney transplantation / Organ transplantation / Medicine / Transplantation medicine / Organ transplants

July 17, 2008 Astellas Receives a Japanese Marketing Approval for the Immunosuppressant Graceptor ®

Add to Reading List

Source URL: www.astellas.com

Language: English - Date: 2008-09-17 23:40:21
583Medicine / Regeneron / Immunology / Pharmaceutical industry / Astellas Pharma / Monoclonal antibodies / Pharmaceutical industry in India / Rilonacept / Biopharmaceutical / Biotechnology / Immunosuppressants / Biology

FOR IMMEDIATE RELEASE Press Release Astellas to Pay $295 Million to Extend License of Regeneron’s VelocImmune® Antibody Technology through 2023 Tarrytown, NY and Tokyo, Japan – (July 28, 2010) –Regeneron Pharmaceu

Add to Reading List

Source URL: www.astellas.com

Language: English - Date: 2010-07-28 00:50:35
584Macrolides / Tacrolimus / Astellas Pharma / Organ transplants / Transplantation medicine / Immunosuppressive drug / Organ transplantation / Transplant rejection / Immunosuppression / Medicine / Immunology / Immunosuppressants

PDF Document

Add to Reading List

Source URL: www.astellas.com

Language: English - Date: 2008-09-18 21:20:54
585Tacrolimus / Kidney transplantation / Astellas Pharma / Mycophenolic acid / Transplant rejection / Immunosuppression / Heart transplantation / Liver transplantation / Ciclosporin / Medicine / Immunosuppressants / Organ transplants

March 20, 2007 Astellas Receives an FDA Action Letter for Prograf sNDA Japan, March 20, [removed]Astellas Pharma Inc. (headquarters: Tokyo, president and CEO: Masafumi Nogimori) today announced that its US subsidiary, Ast

Add to Reading List

Source URL: www.astellas.com

Language: English - Date: 2008-09-18 21:34:04
586Immunosuppressants / Macrolides / Tacrolimus / Astellas Pharma / Graft-versus-host disease / Transplant rejection / Medicine / Transplantation medicine / Health

May 30, 2006 Application for the immunosuppressant FK506 Modified Release Formulation in Japan Japan, May 30, [removed]Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and CEO: Toichi Takenaka) today a

Add to Reading List

Source URL: www.astellas.com

Language: English - Date: 2008-09-19 00:58:14
587Health / Pharmacology / Macrolides / Tacrolimus / Astellas Pharma / European Medicines Agency / Immunosuppressive drug / Transplant rejection / Committee for Medicinal Products for Human Use / Medicine / Pharmaceutical industry / Immunosuppressants

achanA April 27, 2007 Astellas Receives an European Commission Approval for Advagraf

Add to Reading List

Source URL: www.astellas.com

Language: English - Date: 2008-09-18 21:27:09
588Immunosuppressants / Macrolides / Tacrolimus / Astellas Pharma / Colitis / Autoimmune diseases / Ulcerative colitis / Intestine / Atopic dermatitis / Health / Medicine / Gastroenterology

June 23, 2008 Submit an sNDA for the immunosuppressant Prograf® for Ulcerative Colitis in Japan Japan, June 23, [removed]Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and CEO: Masafumi Nogimori) to

Add to Reading List

Source URL: www.astellas.com

Language: English - Date: 2008-09-17 23:51:41
589Macrolides / Tacrolimus / Transplantation medicine / Astellas Pharma / Immunosuppressive drug / Kidney transplantation / Transplant rejection / Organ transplantation / Heart transplantation / Medicine / Organ transplants / Immunosuppressants

September 19, 2007 Astellas Submitted a Response to the FDA Action Letter for FK506 Modified Release Formulation for Kidney Transplantation Japan, September 19, [removed]Astellas Pharma Inc. (headquarters: Tokyo, presiden

Add to Reading List

Source URL: www.astellas.com

Language: English - Date: 2008-09-18 20:50:47
590Eculizumab / Immunosuppressants / Patient safety / Medical necessity / Pharmacy / Medicine / Health / Medical terms

MEDICAL ASSISTANCE BULLETIN ISSUE DATE EFFECTIVE DATE

Add to Reading List

Source URL: www.dhs.state.pa.us

Language: English - Date: 2015-01-09 14:27:08
UPDATE